AXSM · Axsome Therapeutics, Inc. · Documents
$145.04
-11.03 (-7.07%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$7.60B
Shares
52.38M
Volume · Oct 23
1.59M
Avg daily vol (3M)
738.87K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2022-10-03 | — | |
| 8-K | — | 2022-09-29 | — | |
| 8-K | — | 2022-09-08 | — | |
| 8-K | — | 2022-09-01 | — | |
| 8-K | — | 2022-08-23 | 2022-08-19 | |
| 8-K | — | 2022-08-22 | 2022-08-19 | |
| 8-K | — | 2022-08-19 | — | |
| 8-K | — | 2022-08-09 | — | |
| 10-Q | — | 2022-08-09 | 2022-06-30 | |
| 8-K/A | — | 2022-07-21 | 2022-05-09 | |
| 8-K | — | 2022-06-28 | — | |
| 8-K | — | 2022-06-27 | 2022-06-24 | |
| 8-K | — | 2022-06-07 | 2022-06-03 | |
| 8-K | — | 2022-06-02 | — | |
| 8-K | — | 2022-06-01 | — | |
| 8-K | — | 2022-05-31 | — | |
| 8-K | — | 2022-05-18 | — | |
| 8-K | — | 2022-05-09 | — | |
| 10-Q | — | 2022-05-02 | 2022-03-31 | |
| 8-K | — | 2022-05-02 | 2022-04-29 | |
| 8-K | — | 2022-04-25 | 2022-04-22 | |
| DEF 14A | — | 2022-04-22 | — | |
| 8-K | — | 2022-04-19 | — | |
| 8-K/A | — | 2022-03-31 | 2022-03-25 | |
| 8-K | — | 2022-03-28 | 2022-03-25 | |
| 10-K | — | 2022-03-01 | 2021-12-31 | |
| 8-K | — | 2022-03-01 | — | |
| 8-K | — | 2022-03-01 | — | |
| 8-K | — | 2022-02-07 | — | |
| 8-K | — | 2022-01-18 | — | |
| 8-K | — | 2021-11-10 | — | |
| 8-K | — | 2021-11-08 | — | |
| 10-Q | — | 2021-11-08 | 2021-09-30 | |
| 8-K | — | 2021-10-18 | 2021-10-14 | |
| 8-K | — | 2021-09-16 | — | |
| 8-K | — | 2021-09-14 | — | |
| 8-K | — | 2021-08-23 | — | |
| 10-Q | — | 2021-08-09 | 2021-06-30 | |
| 8-K | — | 2021-08-09 | — | |
| 8-K | — | 2021-07-13 | — | |
| 8-K | — | 2021-06-15 | — | |
| 8-K | — | 2021-06-08 | 2021-06-04 | |
| 8-K | — | 2021-05-10 | — | |
| 10-Q | — | 2021-05-10 | 2021-03-31 | |
| 8-K | — | 2021-04-26 | — | |
| DEF 14A | — | 2021-04-23 | 2021-06-04 | |
| 8-K | — | 2021-03-01 | — | |
| 10-K | — | 2021-03-01 | 2020-12-31 | |
| 8-K | — | 2021-02-24 | — | |
| 8-K | — | 2021-01-28 | — |
Showing 101–150 of 187 filings
Key facts
CIK
1579428
CUSIP
05464T104
13F (30d)
67 filings
63 filers
Visit website
Investor relations